Panacea Biotec Balance Sheet
- Market cap
- ₹2,122 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹249.48 – ₹467.78
As of FY25, Panacea Biotec had total assets of ₹1,380 crore and borrowings of ₹255 crore, against shareholders' equity of ₹1,075 crore — a debt-to-equity ratio of 0.35.
Panacea Biotec balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 955 |
| Borrowings | 255 |
| Other liabilities | 170 |
| Total liabilities | 1,380 |
| Fixed assets | 743 |
| Capital work in progress | 45 |
| Investments | 318 |
| Other assets | 318 |
| Total assets | 1,380 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹121.58
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Panacea Biotec balance sheet — frequently asked questions
What is the total debt of Panacea Biotec?
Panacea Biotec reported borrowings of ₹255 crore as of FY25.
What is Panacea Biotec's debt-to-equity ratio?
Based on the FY25 balance sheet, Panacea Biotec's debt-to-equity ratio is 0.35 — borrowings of ₹255 crore against equity capital and reserves of ₹1,075 crore.
What are Panacea Biotec's total assets?
Panacea Biotec's total assets were ₹1,380 crore as of FY25, including fixed assets of ₹743 crore and investments of ₹318 crore.
What is the book value per share of Panacea Biotec?
The book value per share of Panacea Biotec is ₹121.58, based on the latest reported balance sheet.
Same Data For Peers
Trade Panacea Biotec With ATS
Track PANACEABIO live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.